Apellis Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US03753U1060

SecurityAPLS / Apellis Pharmaceuticals, Inc.
InsiderDunlop A. Sinclair
This page shows the track record and history of Dunlop A. Sinclair insider trades in Apellis Pharmaceuticals, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Dunlop A. Sinclair in APLS / Apellis Pharmaceuticals, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

APLS / Apellis Pharmaceuticals, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Dunlop A. Sinclair in APLS / Apellis Pharmaceuticals, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2024-03-19 18,681 57.1790 18,681 57.1790 1,068,161 349 24.0600 -618,695 -57.92
2023-12-01 24,000 61.1350 24,000 61.1350 1,467,240
2023-11-17 8,894 49.9910 8,894 49.9910 444,620
2023-10-17 24,000 49.0000 24,000 49.0000 1,176,000
2022-09-08 15,000 65.0000 15,000 65.0000 975,000
2022-08-11 30,000 65.6300 30,000 65.6300 1,968,900
2022-06-27 1,341 46.7881 1,341 46.7881 62,743
2022-06-23 15,000 45.0000 15,000 45.0000 675,000
2021-05-20 5,773 48.1000 5,773 48.1000 277,681
2021-05-19 7,612 50.0000 7,612 50.0000 380,600
2021-05-18 64,179 51.6600 64,179 51.6600 3,315,487
2021-05-18 14,216 52.6300 14,216 52.6300 748,188
2021-05-18 36,387 53.7800 36,387 53.7800 1,956,893
2021-05-18 22,318 54.5700 22,318 54.5700 1,217,893
2021-05-18 1,200 52.0100 1,200 52.0100 62,412
2021-05-18 10,388 53.5000 10,388 53.5000 555,758
2021-05-18 800 54.0200 800 54.0200 43,216
2020-12-14 7,654 53.8600 7,654 53.8600 412,244
2020-12-14 17,132 55.0100 17,132 55.0100 942,431
2020-12-14 214 56.2500 214 56.2500 12,038
2020-12-07 9,094 50.4100 9,094 50.4100 458,429
2020-12-07 9,470 51.0000 9,470 51.0000 482,970
2020-12-04 5,052 50.0400 5,052 50.0400 252,802
2020-12-04 1,384 51.0500 1,384 51.0500 70,653
2019-12-20 25,000 29.5300 25,000 29.5300 738,250
2019-12-19 54,110 28.9900 54,110 28.9900 1,568,649
2019-12-19 31,000 29.5100 31,000 29.5100 914,810
2019-12-18 25,890 28.5500 25,890 28.5500 739,160

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

APLS / Apellis Pharmaceuticals, Inc. Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2025-09-19 2025-09-19 4 Dunlop A. Sinclair Indirect Owner (Epidarex) APLS Common Stock J - Other I -3,837 65,071
2025-09-19 2025-09-19 4 Dunlop A. Sinclair Indirect Owner (Epidarex) APLS Common Stock S - Sale I 22.9500 -31,092 -714 68,908
2025-01-03 2025-01-01 4 Dunlop A. Sinclair APLS Common Stock A - Award D 6,267 158,393
2024-09-24 2024-09-23 4 Dunlop A. Sinclair APLS Common Stock M - Exercise D 13.1900 4,600 61 152,126
2024-09-17 2024-09-16 4 Dunlop A. Sinclair Indirect Owner (Epidarex) APLS Common Stock S - Sale I 36.7900 -7,524 -277 100,000
2024-09-17 2024-09-16 4 Dunlop A. Sinclair Indirect Owner (Epidarex) APLS Common Stock S - Sale I 36.0900 -29,476 -1,064 107,524
2024-07-01 2024-06-28 4 Dunlop A. Sinclair APLS Common Stock M - Exercise D 13.1900 900 12 134,418
2024-06-21 2024-06-21 4 Dunlop A. Sinclair Indirect Owner (Epidarex) APLS Common Stock S - Sale I 39.6300 -1,695 -67 136,998
2024-06-21 2024-06-21 4 Dunlop A. Sinclair Indirect Owner (Epidarex) APLS Common Stock S - Sale I 39.2200 -35,305 -1,385 138,693
2024-04-15 2024-04-12 4 Dunlop A. Sinclair APLS Common Stock M - Exercise D 13.1900 1,500 20 133,518
2024-03-20 2024-03-19 4 Dunlop A. Sinclair Indirect Owner (Epidarex) APLS Common Stock S - Sale I 57.1790 -18,681 -1,068 173,998
2024-01-02 2024-01-01 4 Dunlop A. Sinclair APLS Common Stock A - Award D 3,341 132,018
2023-12-15 2023-12-14 4 Dunlop A. Sinclair APLS Common Stock M - Exercise D 13.1900 6,274 83 128,677
2023-12-05 2023-12-01 4 Dunlop A. Sinclair Indirect Owner (Epidarex) APLS Common Stock S - Sale I 61.1350 -24,000 -1,467 192,679
2023-11-21 2023-11-17 4 Dunlop A. Sinclair APLS Common Stock S - Sale D 49.9910 -8,894 -445 122,403
2023-11-21 2023-10-17 4 Dunlop A. Sinclair Indirect Owner (Epidarex) APLS Common Stock S - Sale I 49.0000 -24,000 -1,176 216,679
2023-04-05 2023-04-03 4 Dunlop A. Sinclair APLS Common Stock S - Sale D 74.0500 -500 -37 131,297
2023-03-02 2023-03-01 4 Dunlop A. Sinclair APLS Common Stock S - Sale D 65.3300 -500 -33 131,797
2023-02-02 2023-02-01 4 Dunlop A. Sinclair APLS Common Stock S - Sale D 52.6100 -500 -26 132,297
2023-01-05 2023-01-03 4 Dunlop A. Sinclair APLS Common Stock S - Sale D 50.7000 -500 -25 132,797
2023-01-04 2023-01-01 4 Dunlop A. Sinclair APLS Common Stock A - Award D 3,867 133,297
2022-12-02 2022-12-01 4 Dunlop A. Sinclair APLS Common Stock S - Sale D 49.9300 -500 -25 129,430
2022-11-03 2022-11-01 4 Dunlop A. Sinclair APLS Common Stock S - Sale D 60.8300 -500 -30 129,930
2022-09-08 2022-09-08 4 Dunlop A. Sinclair Indirect Owner (Epidarex) APLS Common Stock S - Sale I 65.0000 -15,000 -975 240,679
2022-08-26 2022-08-25 4 Dunlop A. Sinclair APLS Common Stock M - Exercise D 13.1900 4,306 57 130,430
2022-08-17 2022-08-16 4 Dunlop A. Sinclair APLS Common Stock M - Exercise D 14.0000 25,394 356 126,124
2022-08-12 2022-08-11 4 Dunlop A. Sinclair Indirect Owner (Epidarex) APLS Common Stock S - Sale I 65.6300 -30,000 -1,969 255,679
2022-07-22 2022-07-21 4 Dunlop A. Sinclair APLS Common Stock M - Exercise D 14.0000 9,606 134 100,730
2022-06-29 2022-06-27 4 Dunlop A. Sinclair Indirect Owner (ECM) APLS Common Stock S - Sale I 46.7881 -1,341 -63 1,341
2022-06-24 2022-06-23 4 Dunlop A. Sinclair Indirect Owner (Epidarex) APLS Common Stock S - Sale I 45.0000 -15,000 -675 285,679
2022-04-25 2022-04-22 4 Dunlop A. Sinclair APLS Stock Option (Right to Buy) M - Exercise D 14.00 -20,000 35,000
2022-04-25 2022-04-22 4 Dunlop A. Sinclair APLS Common Stock M - Exercise D 14.0000 20,000 280 91,124
2022-01-04 2022-01-01 4 Dunlop A. Sinclair APLS Stock Option (Right to Buy) A - Award D 47.28 8,554 8,554
2022-01-04 2022-01-01 4 Dunlop A. Sinclair APLS Common Stock A - Award D 4,230 71,124
2021-09-13 2021-09-10 4 Dunlop A. Sinclair APLS Stock Option (Right to Buy) M - Exercise D 14.00 -6,894 55,000
2021-09-13 2021-09-10 4 Dunlop A. Sinclair APLS Common Stock M - Exercise D 14.0000 6,894 97 66,894
2021-06-02 2021-06-01 4 Dunlop A. Sinclair APLS Common Stock J - Other I 2,682 303,361
2021-06-02 2021-06-01 4 Dunlop A. Sinclair APLS Common Stock J - Other D 13,108 73,108
2021-06-02 2021-06-01 4 Dunlop A. Sinclair APLS Common Stock J - Other I -31,855 0
2021-05-20 2021-05-20 4 Dunlop A. Sinclair APLS Common Stock S - Sale I 48.1000 -5,773 -278 31,855
2021-05-20 2021-05-19 4 Dunlop A. Sinclair APLS Common Stock S - Sale I 50.0000 -7,612 -381 300,679
2021-05-20 2021-05-18 4 Dunlop A. Sinclair APLS Common Stock S - Sale I 54.0200 -800 -43 308,291
2021-05-20 2021-05-18 4 Dunlop A. Sinclair APLS Common Stock S - Sale I 53.5000 -10,388 -556 309,091
2021-05-20 2021-05-18 4 Dunlop A. Sinclair APLS Common Stock S - Sale I 52.0100 -1,200 -62 319,479
2021-05-20 2021-05-18 4 Dunlop A. Sinclair APLS Common Stock S - Sale I 54.5700 -22,318 -1,218 37,628
2021-05-20 2021-05-18 4 Dunlop A. Sinclair APLS Common Stock S - Sale I 53.7800 -36,387 -1,957 59,946
2021-05-20 2021-05-18 4 Dunlop A. Sinclair APLS Common Stock S - Sale I 52.6300 -14,216 -748 96,333
2021-05-20 2021-05-18 4 Dunlop A. Sinclair APLS Common Stock S - Sale I 51.6600 -64,179 -3,315 110,549
2021-04-26 2021-04-23 4 Dunlop A. Sinclair APLS Stock Option (Right to Buy) M - Exercise D 14.00 -10,000 61,894
2021-04-26 2021-04-23 4 Dunlop A. Sinclair APLS Common Stock M - Exercise D 14.0000 10,000 140 60,000
2021-04-19 2021-04-16 4 Dunlop A. Sinclair APLS Stock Option (Right to Buy) M - Exercise D 14.00 -50,000 71,894
2021-04-19 2021-04-16 4 Dunlop A. Sinclair APLS Common Stock M - Exercise D 14.0000 50,000 700 50,000
2021-01-04 2021-01-01 4 Dunlop A. Sinclair APLS Stock Option (Right to Buy) A - Award D 57.20 27,600 27,600
2020-12-15 2020-12-14 4 Dunlop A. Sinclair APLS Common Stock S - Sale I 56.2500 -214 -12 174,728
2020-12-15 2020-12-14 4 Dunlop A. Sinclair APLS Common Stock S - Sale I 55.0100 -17,132 -942 174,942
2020-12-15 2020-12-14 4 Dunlop A. Sinclair APLS Common Stock S - Sale I 53.8600 -7,654 -412 192,074
2020-12-07 2020-12-07 4 Dunlop A. Sinclair APLS Common Stock S - Sale I 51.0000 -9,470 -483 199,728
2020-12-07 2020-12-07 4 Dunlop A. Sinclair APLS Common Stock S - Sale I 50.4100 -9,094 -458 209,198
2020-12-07 2020-12-04 4 Dunlop A. Sinclair APLS Common Stock S - Sale I 51.0500 -1,384 -71 218,292
2020-12-07 2020-12-04 4 Dunlop A. Sinclair APLS Common Stock S - Sale I 50.0400 -5,052 -253 219,676
2020-01-03 2020-01-01 4 Dunlop A. Sinclair APLS Stock Option (Right to Buy) A - Award D 30.62 30.6200 27,600 845 27,600
2019-12-20 2019-12-20 4 Dunlop A. Sinclair APLS Common Stock S - Sale I 29.5300 -25,000 -738 224,728
2019-12-20 2019-12-19 4 Dunlop A. Sinclair APLS Common Stock S - Sale I 29.5100 -31,000 -915 249,728
2019-12-20 2019-12-19 4 Dunlop A. Sinclair APLS Common Stock S - Sale I 28.9900 -54,110 -1,569 320,681
2019-12-20 2019-12-18 4 Dunlop A. Sinclair APLS Common Stock S - Sale I 28.5500 -25,890 -739 374,791
2019-01-03 2019-01-01 4 Dunlop A. Sinclair APLS Stock option (right to buy) A - Award D 13.19 17,580 17,580
2018-05-09 2018-05-07 4 Dunlop A. Sinclair APLS Common Stock J - Other I 94,357 280,728
2017-11-13 2017-11-13 4 Dunlop A. Sinclair APLS Series E Preferred Stock C - Conversion I -6,078 0
2017-11-13 2017-11-13 4 Dunlop A. Sinclair APLS Series D Preferred Stock C - Conversion I -31,478 0
2017-11-13 2017-11-13 4 Dunlop A. Sinclair APLS Series C Preferred Stock C - Conversion I -150,023 0
2017-11-13 2017-11-13 4 Dunlop A. Sinclair APLS Series B Preferred Stock C - Conversion I -213,100 0
2017-11-13 2017-11-13 4 Dunlop A. Sinclair APLS Common Stock C - Conversion I 400,679 400,679
2017-11-08 3 Dunlop A. Sinclair APLS Common Stock I 372,742
2017-11-08 3 Dunlop A. Sinclair APLS Common Stock I 372,742
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)